Početna › Skleroderma › Texas › Houston
Kliničke studije za Skleroderma u gradu Houston, TX
9 studija za Skleroderma traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
U tijeku regrutacijaFaza 3
- The University of Texas Health Science Center at Houston, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
U tijeku regrutacijaFaza 1
- UT MD Anderson Cancer Center, Houston
Platform Clinical Study for Conquering Scleroderma
U tijeku regrutacijaFaza 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
U tijeku regrutacijaFaza 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
U tijeku regrutacijaFaza 2
- Artiva Investigational Site Bellaire, Bellaire · 7 mi udaljenosti
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
U tijeku regrutacijaFaza 2
- The University of Texas Health Science Center at Houston, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
U tijeku regrutacijaFaza 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
U tijeku regrutacija
- The University of Texas Health Science Center at Houston, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
U tijeku regrutacijaFaza 2
- aTyr Investigative Site, Houston
Studije za Skleroderma u drugim gradovima
- New York City, NY11 studija
- Ann Arbor, MI10 studija
- Chicago, IL10 studija
- Boston, MA7 studija
- Durham, NC7 studija
- Los Angeles, CA7 studija
- New Orleans, LA6 studija
- Baltimore, MD6 studija
- Philadelphia, PA6 studija
- Dallas, TX5 studija
- Pittsburgh, PA5 studija
- Plantation, FL4 studija
Ostale studije u gradu Houston
- Nemikrocelularni karcinom pluća145 studija
- Rak dojke126 studija
- Rak (sve vrste)121 studija
- Metastatski karcinom104 studija
- Kolorektalni rak102 studija
- Rak jajnika89 studija
- Akutna mijeloična leukemija85 studija
- Rak pluća78 studija
- Rak prostate76 studija
- Rak endometrija68 studija
- Rak gušterače61 studija
- Melanom59 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.